Literature DB >> 20842046

The progressive pathway of microalbuminuria: from early marker of renal damage to strong cardiovascular risk predictor.

Giovanni Cerasola1, Santina Cottone, Giuseppe Mulè.   

Abstract

There is clear evidence that urinary albumin excretion levels, even below the cut-off values currently used to diagnose microalbuminuria, are associated with an increased risk of cardiovascular events. The relationships of microalbuminuria with a variety of risk factors, such as hypertension, diabetes and metabolic syndrome and with several indices of subclinical organ damage, may contribute, at least in part, to explain the enhanced cardiovascular risk conferred by microalbuminuria. Nonetheless, several studies showed that the association between microalbuminuria and cardiovascular disease remains when all these risk factors are taken into account in multivariate analyses. Therefore, the exact pathophysiological mechanisms explaining the association between microalbuminuria and cardiovascular risk remain incompletely understood. The simple search for microalbuminuria in hypertensive patients may enable the clinician to better assess absolute cardiovascular risk, and its identification may induce physicians to encourage patients to make healthy lifestyle changes and perhaps would prompt to more aggressive modification of standard cardiovascular risk factors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20842046     DOI: 10.1097/HJH.0b013e32833ec377

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  31 in total

1.  Predicting diabetic nephropathy by serum proteomic profiling in patients with type 2 diabetes.

Authors:  Yehong Yang; Shuo Zhang; Bin Lu; Wei Gong; Xuehong Dong; Xiaoyan Song; Weiwei Zhao; Jiefeng Cui; Yinkun Liu; Renming Hu
Journal:  Wien Klin Wochenschr       Date:  2015-05-19       Impact factor: 1.704

2.  The nephroprotective effect of sacubitril/valsartan in heart failure: insights from the real-life clinical setting.

Authors:  Giuseppe Mulè; Alessandra Sorce; Emilio Nardi; Giulio Geraci; Santina Cottone
Journal:  Intern Emerg Med       Date:  2019-07-15       Impact factor: 3.397

Review 3.  Cardiovascular risk.

Authors:  Rupert A Payne
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

4.  Prognostic impact of baseline urinary albumin excretion rate in patients with resistant hypertension: a prospective cohort study.

Authors:  Paula Moreira da Costa; Arthur Fernandes Cortez; Fabio de Souza; Gabriel de Souza Mares; Bruno Dussoni Moreira Dos Santos; Elizabeth Silaid Muxfeldt
Journal:  J Hum Hypertens       Date:  2017-12-11       Impact factor: 3.012

Review 5.  Metabolic syndrome in hypertensive patients: An unholy alliance.

Authors:  Giuseppe Mulè; Ilenia Calcaterra; Emilio Nardi; Giovanni Cerasola; Santina Cottone
Journal:  World J Cardiol       Date:  2014-09-26

Review 6.  Linagliptin: an update of its use in patients with type 2 diabetes mellitus.

Authors:  Kate McKeage
Journal:  Drugs       Date:  2014-10       Impact factor: 9.546

7.  Average real variability of 24-h systolic blood pressure is associated with microalbuminuria in patients with primary hypertension.

Authors:  G Mulè; I Calcaterra; M Costanzo; M Morreale; F D'Ignoto; A Castiglia; G Geraci; G Rabbiolo; F Vaccaro; S Cottone
Journal:  J Hum Hypertens       Date:  2015-06-18       Impact factor: 3.012

8.  Role of PPARα and Its Agonist in Renal Diseases.

Authors:  Ching-Feng Cheng; Hsi-Hsien Chen; Heng Lin
Journal:  PPAR Res       Date:  2010-11-08       Impact factor: 4.964

9.  Relationship Between Short-Term Blood Pressure Variability and Subclinical Renal Damage in Essential Hypertensive Patients.

Authors:  Giuseppe Mulè; Ilenia Calcaterra; Miriam Costanzo; Giulio Geraci; Laura Guarino; Anna C Foraci; Maria G Vario; Giovanni Cerasola; Santina Cottone
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-23       Impact factor: 3.738

10.  Metabolite Signature of Albuminuria Involves Amino Acid Pathways in 8661 Finnish Men Without Diabetes.

Authors:  Lilian Fernandes Silva; Jagadish Vangipurapu; Ulf Smith; Markku Laakso
Journal:  J Clin Endocrinol Metab       Date:  2021-01-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.